INBX logo

Inhibrx Biosciences, Inc. (INBX)

Profile

Full Name

Inhibrx Biosciences, Inc.

Ticker

NASDAQ: INBX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 4, 2024

Indexes

Not included

Website

https://inhibrx.com

Employees

156

Key Details

Price

$84.12(0.55%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$200.00K(-88.89% YoY)

Annual EPS

$116.58(799.19% YoY)

PE Ratio

-

Next earnings date

Mar 31, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $84.12
    INBX price is $84.12

    30-Day Relative Volume

    0.15
    INBX 30-day relative volume is 0.15

    Price Performance

    Price Most Recent Change

    +0.55%
    INBX price was up +0.55% on Nov 28, 2025

    Price YTD Change

    +446.23%
    INBX price is up +446.23% since January 1st

    Price 1-Year Change

    +438.2%
    INBX price is up +438.2% year-on-year

    Price 3-Year Change

    +190.07%
    INBX price is up +190.07% over the past 3 years

    Price Range

    Price All-Time High

    $87.83
    INBX price is currently -4.23% below its historical high of $87.83

    Price 3-Year Low

    $10.80
    INBX price is currently +678.89% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $1.22B
    INBX market cap is $1.22 billion

    Market Cap 3-Year Change

    -3.58%
    INBX market cap is down -3.58% over the past 3 years

    Market Cap All-Time High

    $1.89B
    INBX market cap is currently -35.42% below its historical high of $1.89 billion

    Market Cap Sector Percentile

    72.62%
    INBX market cap is higher than 72.62% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    INBX shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    -66.76%
    INBX shares outstanding is down -66.76% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.08
    INBX beta is 1.08

    200-day SMA

    $26.73
    INBX price is currently +214.71% above its 200-day simple moving average

    50-day SMA

    $55.56
    INBX price is currently +51.40% above its 50-day simple moving average

    14-Day RSI

    68.79
    INBX 14-day relative strength index is 68.79

    Volume

    0.15
    INBX 30-day relative volume is 0.15

    ATR

    $6.35
    INBX average true range is $6.35

    10-day Historical Volatility

    56.06%
    INBX 10-day historical volatility is 56.06%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $200.00K
    INBX annual revenue is $200.00 thousand

    Revenue Analysts Estimate

    $1.30M
    INBX annual revenue is currently -84.62% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -88.89%
    INBX annual revenue is down -88.89% year-on-year

    Revenue Sector Percentile

    32.64%
    INBX annual revenue is higher than 32.64% of companies in Healthcare sector

    EPS

    EPS

    $116.58
    INBX annual earnings per share is $116.58

    EPS Analysts Estimate

    -$9.01
    INBX annual earnings per share is currently +1393.87% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +799.19%
    INBX annual earnings per share is up +799.19% year-on-year

    EPS Sector Percentile

    100%
    INBX annual earnings per share is higher than 100% of companies in Healthcare sector

    Profit

    Gross Profit

    -$2.08M
    INBX annual gross profit is -$2.08 million

    Gross Margin

    -1042.50%
    INBX annual gross profit margin is -1042.50%

    Operating Profit

    -$331.45M
    INBX annual operating income is -$331.45 million

    Operating Margin

    -165.72K%
    INBX annual operating profit margin is -165.72 thousand%

    Net Income

    $1.69B
    INBX annual net profit is $1.69 billion

    Net Margin

    -
    INBX annual net profit margin value is unknown

    Expenses

    Total Expenses

    $331.65M
    INBX annual total expenses is $331.65 million

    Operating Expenses

    $331.65M
    INBX annual total operating expenses is $331.65 million

    Cost Of Goods Sold

    $2.29M
    INBX annual cost of goods sold is $2.29 million

    Selling, General & Administrative Expenses

    $127.91M
    INBX annual SG&A is $127.91 million

    Depreciation & Amortization

    $2.29M
    INBX annual D&A is $2.29 million

    Interest Expense

    $13.49M
    INBX annual interest expense is $13.49 million

    Income Tax

    $2000.00
    INBX annual income tax is $2000.00

    EBIT & EBITDA

    EBIT

    -$331.45M
    INBX annual earnings before interest & taxes is -$331.45 million

    EBITDA

    -$331.45M
    INBX annual EBITDA is -$331.45 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $180.77M
    INBX annual total assets is $180.77 million

    Non Current Assets

    $20.37M
    INBX annual long term assets is $20.37 million

    Current Assets

    $160.40M
    INBX annual total current assets is $160.40 million

    Cash and Cash Equivalents

    $152.60M
    INBX annual cash & cash equivalents is $152.60 million

    Accounts Receivable

    $397.00K
    INBX annual accounts receivable is $397.00 thousand

    Inventory

    $0.00
    INBX annual inventory is $0.00

    Liabilities

    Total Liabilities

    $47.18M
    INBX annual total liabilities is $47.18 million

    Long Term Liabilities

    $6.45M
    INBX annual total long term liabilities is $6.45 million

    Current Liabilities

    $40.73M
    INBX annual current liabilities is $40.73 million

    Accounts Payable

    $9.24M
    INBX annual accounts payable is $9.24 million

    Debt

    Total Debt

    $8.05M
    INBX annual total debt is $8.05 million

    Total Debt 1-Year Change

    -96.17%
    INBX annual total debt is down -96.17% year-on-year

    Long Term Debt

    $6.45M
    INBX annual long term debt is $6.45 million

    Short Term Debt

    $1.59M
    INBX annual short term debt is $1.59 million

    Equity & Capital

    Shareholders Equity

    $133.58M
    INBX annual stockholders equity is $133.58 million

    Book Value

    $133.58M
    INBX annual book value is $133.58 million

    Retained Earnings

    -$106.13M
    INBX annual retained earnings is -$106.13 million

    Working Capital

    $119.67M
    INBX annual working capital is $119.67 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$194.41M
    INBX annual cash from operations is -$194.41 million

    Cash From Operations 1-Year Change

    -0.57%
    INBX annual cash from operations is down -0.57% year-on-year

    Cash From Investing

    -$2.60M
    INBX annual cash from investing is -$2.60 million

    Cash From Investing 1-Year Change

    +43.46%
    INBX annual cash from investing is up +43.46% year-on-year

    Cash From Financing

    $71.68M
    INBX annual cash from financing is $71.68 million

    Cash From Financing 1-Year Change

    -64.51%
    INBX annual cash from financing is down -64.51% year-on-year

    CAPEX

    CAPEX

    $2.60M
    INBX annual capital expenditures is $2.60 million

    CAPEX 1-Year Change

    -43.46%
    INBX annual capital expenditures is down -43.46% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$197.01M
    INBX annual free cash flow is -$197.01 million

    Free Cash Flow 1-Year Change

    +0.45%
    INBX annual free cash flow is up +0.45% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -1042.50%
    INBX annual gross profit margin is -1042.50%

    Operating Margin

    -165.72K%
    INBX annual operating profit margin is -165.72 thousand%

    Net Margin

    -
    INBX annual net profit margin value is unknown

    ROA & ROE

    ROA

    690.69%
    INBX annual return on assets is 690.69%

    ROE

    1905.92%
    INBX annual return on equity is 1905.92%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    INBX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    INBX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    33.06
    INBX price to book ratio is 33.06

    PB Ratio Sector Percentile

    96.01%
    INBX price to book ratio is higher than 96.01% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    869.79
    INBX price to sales ratio is 869.79

    PS Ratio Sector Percentile

    96.74%
    INBX price to sales ratio is higher than 96.74% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $1.17B
    INBX enterprise value is $1.17 billion

    Enterprise Value Sector Percentile

    72.99%
    INBX enterprise value is higher than 72.99% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -7.74
    INBX EV/EBITDA is -7.74

    EV/EBITDA Sector Percentile

    18.77%
    INBX EV/EBITDA is higher than 18.77% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    3.94
    INBX annual current ratio is 3.94

    Quick Ratio

    3.94
    INBX annual quick ratio is 3.94

    Leverage

    Debt To Equity

    0.00
    INBX annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -24.57
    INBX annual interest coverage ratio is -24.57

    Risk & Stability

    F-Score

    -
    INBX piotroski f-score value is unknown

    Altman Z-Score

    9.41
    INBX altman z-score is 9.41

    Analyst ratings

    Recent major analysts updates

    Aug 22, 25 JMP Securities
    Market Perform
    May 15, 25 JMP Securities
    Market Perform
    Mar 18, 25 Citizens Capital Markets
    Market Perform
    Jan 22, 25 JMP Securities
    Market Perform
    Jul 23, 24 JMP Securities
    Market Perform
    Jan 23, 24 JMP Securities
    Market Perform
    Nov 20, 23 JMP Securities
    Market Outperform
    Aug 23, 23 JMP Securities
    Outperform
    May 10, 23 JMP Securities
    Market Outperform
    Mar 8, 23 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with INBX included

    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks recommended to hold
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    • What is the ticker symbol for Inhibrx Biosciences, Inc.?
    • Does Inhibrx Biosciences, Inc. pay dividends?
    • What sector is Inhibrx Biosciences, Inc. in?
    • What industry is Inhibrx Biosciences, Inc. in?
    • What country is Inhibrx Biosciences, Inc. based in?
    • When did Inhibrx Biosciences, Inc. go public?
    • Is Inhibrx Biosciences, Inc. in the S&P 500?
    • Is Inhibrx Biosciences, Inc. in the NASDAQ 100?
    • Is Inhibrx Biosciences, Inc. in the Dow Jones?
    • When was Inhibrx Biosciences, Inc.'s last earnings report?
    • When does Inhibrx Biosciences, Inc. report earnings?

    What is the ticker symbol for Inhibrx Biosciences, Inc.?

    The ticker symbol for Inhibrx Biosciences, Inc. is NASDAQ:INBX

    Does Inhibrx Biosciences, Inc. pay dividends?

    No, Inhibrx Biosciences, Inc. does not pay dividends

    What sector is Inhibrx Biosciences, Inc. in?

    Inhibrx Biosciences, Inc. is in the Healthcare sector

    What industry is Inhibrx Biosciences, Inc. in?

    Inhibrx Biosciences, Inc. is in the Biotechnology industry

    What country is Inhibrx Biosciences, Inc. based in?

    Inhibrx Biosciences, Inc. is headquartered in United States

    When did Inhibrx Biosciences, Inc. go public?

    Inhibrx Biosciences, Inc.'s initial public offering (IPO) was on June 4, 2024

    Is Inhibrx Biosciences, Inc. in the S&P 500?

    No, Inhibrx Biosciences, Inc. is not included in the S&P 500 index

    Is Inhibrx Biosciences, Inc. in the NASDAQ 100?

    No, Inhibrx Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Inhibrx Biosciences, Inc. in the Dow Jones?

    No, Inhibrx Biosciences, Inc. is not included in the Dow Jones index

    When was Inhibrx Biosciences, Inc.'s last earnings report?

    Inhibrx Biosciences, Inc.'s most recent earnings report was on November 14, 2025

    When does Inhibrx Biosciences, Inc. report earnings?

    The next expected earnings date for Inhibrx Biosciences, Inc. is March 31, 2026
    On this page